182 related articles for article (PubMed ID: 8195451)
1. Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response.
Beauclair L; Fontaine R; Annable L; Holobow N; Chouinard G
J Clin Psychopharmacol; 1994 Apr; 14(2):111-8. PubMed ID: 8195451
[TBL] [Abstract][Full Text] [Related]
2. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
3. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
[TBL] [Abstract][Full Text] [Related]
4. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
Tesar GE; Rosenbaum JF; Pollack MH; Herman JB; Sachs GS; Mahoney EM; Cohen LS; McNamara M; Goldstein S
J Clin Psychiatry; 1987 Oct; 48 Suppl():16-21. PubMed ID: 3312179
[TBL] [Abstract][Full Text] [Related]
5. Adinazolam sustained-release treatment of panic disorder: a double-blind study.
Davidson JR; Beitman B; Greist JH; Maddock RJ; Lewis CP; Sheridan AQ; Carter C; Krishnan KR; Liebowitz MR; Haack DG
J Clin Psychopharmacol; 1994 Aug; 14(4):255-63. PubMed ID: 7962681
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder.
Nardi AE; Lopes FL; Valença AM; Freire RC; Nascimento I; Veras AB; Mezzasalma MA; de-Melo-Neto VL; Soares-Filho GL; King AL; Grivet LO; Rassi A; Versiani M
Psychiatry Res; 2010 Feb; 175(3):260-5. PubMed ID: 20036427
[TBL] [Abstract][Full Text] [Related]
7. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder.
Pollack MH; Otto MW; Tesar GE; Cohen LS; Meltzer-Brody S; Rosenbaum JF
J Clin Psychopharmacol; 1993 Aug; 13(4):257-63. PubMed ID: 8376613
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages.
Moroz G; Rosenbaum JF
J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979
[TBL] [Abstract][Full Text] [Related]
10. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder.
Worthington JJ; Pollack MH; Otto MW; McLean RY; Moroz G; Rosenbaum JF
Psychopharmacol Bull; 1998; 34(2):199-205. PubMed ID: 9641001
[TBL] [Abstract][Full Text] [Related]
11. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
Modigh K; Westberg P; Eriksson E
J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
[TBL] [Abstract][Full Text] [Related]
13. Effect of fluvoxamine on panic disorder.
Hoehn-Saric R; McLeod DR; Hipsley PA
J Clin Psychopharmacol; 1993 Oct; 13(5):321-6. PubMed ID: 8227490
[TBL] [Abstract][Full Text] [Related]
14. The effects of clonazepam on quality of life and work productivity in panic disorder.
Jacobs RJ; Davidson JR; Gupta S; Meyerhoff AS
Am J Manag Care; 1997 Aug; 3(8):1187-96. PubMed ID: 10170301
[TBL] [Abstract][Full Text] [Related]
15. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial.
Bandelow B; Broocks A; Pekrun G; George A; Meyer T; Pralle L; Bartmann U; Hillmer-Vogel U; Rüther E
Pharmacopsychiatry; 2000 Sep; 33(5):174-81. PubMed ID: 11071019
[TBL] [Abstract][Full Text] [Related]
16. A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam.
Nardi AE; Valença AM; Nascimento I; Lopes FL; Mezzasalma MA; Freire RC; Veras AB; Zin WA; Versiani M
Psychiatry Res; 2005 Nov; 137(1-2):61-70. PubMed ID: 16226812
[TBL] [Abstract][Full Text] [Related]
17. The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma.
Labbate LA; Pollack MH; Otto MW; Tesar GM; Rosenbaum JF
J Clin Psychopharmacol; 1994 Aug; 14(4):274-6. PubMed ID: 7962684
[TBL] [Abstract][Full Text] [Related]
18. Treatment of panic disorder and agoraphobia with clonazepam.
Spier SA; Tesar GE; Rosenbaum JF; Woods SW
J Clin Psychiatry; 1986 May; 47(5):238-42. PubMed ID: 3700341
[TBL] [Abstract][Full Text] [Related]
19. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
[TBL] [Abstract][Full Text] [Related]
20. Double-blind clonazepam vs placebo in panic disorder treatment.
Valença AM; Nardi AE; Nascimento I; Mezzasalma MA; Lopes FL; Zin W
Arq Neuropsiquiatr; 2000 Dec; 58(4):1025-9. PubMed ID: 11105068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
